PARIS/LONDON, Sept 10 (Reuters) - French drugmaker Sanofi-Aventis on Wednesday named GlaxoSmithKline executive Chris Viehbacher as its new CEO, ousting former research head Gerard Le Fur after less than two years in the job.
PARIS/LONDON, Sept 10 (Reuters) - French drugmaker Sanofi-Aventis on Wednesday named GlaxoSmithKline executive Chris Viehbacher as its new CEO, ousting former research head Gerard Le Fur after less than two years in the job.
